Sign in with Google
|
USD 103.09
Price
-0.18
(-0.17%)
Day Change
|
|
|---|
NVS, the overall quality is good (Quality = 77) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is very good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 2 |
| Magic Formula Rank by ROA |
442
|
| Magic Formula Rank by ROE |
442
|
| Magic Formula Rank by ROIC |
908
|
| Price | 103.09 |
| PBV / Sector |
4.76 / 11.55
|
| Earning Per Share | 5.73 |
| PE / Sector |
18.02 / 30.94
|
| PEG or PE/Growth / Sector |
3.08 / 1.34
|
| Average 1M Daily Value |
148.94 M
GREAT
|
| Average 1W Daily Value |
131.81 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| Ability to Make Profit |
|
81% |
| Return to Investors |
|
54% |
| Registration Details |
| Analyze Date | 2024-11-21 20:05:20 |
| Symbol | NVS |
| Name | NOVARTIS AG ADR |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NYSE |
| Listed Shares | 1,999.27 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 206,464.61 / 215,531.71 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
AZN 
GILD 
MRK 
